Showing results (21-30 of 31) with videos related to

Sort By:
Pageof 4
ACS Infectious Diseases|June 29, 2022
Sec61 Inhibitor Apratoxin S4 Potently Inhibits SARS-CoV-2 and Exhibits Broad-Spectrum Antiviral ActivityMarie O Pohl, Laura Martin-Sancho, Ranjala Ratnayake, et al.
Frontiers in Immunology|January 10, 2022
Development of an <i>In Vivo</i> Probe to Track SARS-CoV-2 Infection in Rhesus MacaquesPatrick J Madden, Muhammad S Arif, Mark E Becker, et al.
Proceedings of the National Academy of Sciences of the United States of America|October 24, 2020
SARS-CoV-2 Orf6 hijacks Nup98 to block STAT nuclear import and antagonize interferon signalingLisa Miorin, Thomas Kehrer, Maria Teresa Sanchez-Aparicio, et al.
Biorxiv : the Preprint Server for Biology|October 7, 2020
Functional Landscape of SARS-CoV-2 Cellular RestrictionLaura Martin-Sancho, Mary K Lewinski, Lars Pache, et al.
Plos Biology|June 12, 2025
Global siRNA screen identifies human host factors critical for SARS-CoV-2 replication and late stages of infectionXin Yin, Yuan Pu, Shuofeng Yuan, et al.
Biorxiv : the Preprint Server for Biology|June 9, 2020
A Large-scale Drug Repositioning Survey for SARS-CoV-2 AntiviralsLaura Riva, Shuofeng Yuan, Xin Yin, et al.
Nature Microbiology|September 24, 2021
Restriction factor compendium for influenza A virus reveals a mechanism for evasion of autophagyLaura Martin-Sancho, Shashank Tripathi, Ariel Rodriguez-Frandsen, et al.
Molecular Cell|April 30, 2021
Functional landscape of SARS-CoV-2 cellular restrictionLaura Martin-Sancho, Mary K Lewinski, Lars Pache, et al.
Iscience|October 27, 2025
Integrative multi-omics analysis <i>in vivo</i> identifies influenza virus host factorsLeah P Shriver, Benjamin J Polacco, Manon Eckhardt, et al.
Nature|July 25, 2020
Discovery of SARS-CoV-2 antiviral drugs through large-scale compound repurposingLaura Riva, Shuofeng Yuan, Xin Yin, et al.
Pageof 4